Lidocaine-;often used as numbing agent for outpatient medical procedures-;activates certain bitter taste receptors through two unique mechanisms that result in cancer cell death, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.
UniSA seeks public support for vital research on deadly brain cancers
The University of South Australia is seeking public support for vital brain cancer research that could potentially save hundreds of lives.